Projects / Research / Grants

Hey there mate!


Your lost treasure is not found here…

Check again your spelling and rewrite the content you are seeking for in the search field.

Grants

Grant of 20,000 to 250,000 US dollars for the implementation of a project under IREX

Grant of 20,000 to 250,000 US dollars for the implementation of a project under IREX

Grant of 20,000 to 250,000 US dollars for the implementation of a project under IREX

Grant of 20,000 to 250,000 US dollars for the implementation of a project under IREX

Grant of 20,000 to 250,000 US dollars for the implementation of a project under IREX

Grant of 20,000 to 250,000 US dollars for the implementation of a project under IREX

Awards

Name Awards

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make.

Name Awards

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make.

Grants

Anil Kapoor Grant

Research

Call for Abstracts

The Anil Kapoor Kidney Cancer Research Grant

TERMS OF REFERENCE 2025-2026

Application Submission Deadline: December 15th,2025

Tentative Notification of Finalist Date: January 15th, 2026,

Tentative Finalists Presentation Date: Kidney Cancer Research Network of Canada (KCRNC)
meeting to be held over February 5th – February 7th, 2026.

Submission of Research Updates to KCRNC:
6 months, 1 year, and 1-year post-grant.
Project updates will be requested at future CKCF Meetings.

Application Submissions

All applications are to be submitted electronically via the CUASF website (www.cuasf.org). An email confirmation will be sent following the receipt of your submission. The top three finalists will be notified end of January 2026.
Finalists must be available to present their research proposal during the CKCF 2026 Meeting, scheduled from February 5th – February 7th, 2026, in Toronto, ON. Applicants must also agree to have the session recorded and posted online as an on-demand viewing session.
If you have any questions or require support preparing or submitting your application, please email Marfisa.defrancesco@cua.org

Background

The Canadian Urological Association Scholarship Fund (CUASF), the Kidney Cancer Research Network of Canada (KCRNC), and Kidney Cancer Canada (KCC) provide financial support for research within the Canadian kidney cancer research community.

Objectives and Scope

The objective of The Anil Kapoor Kidney Cancer Research Grant is to support peer-reviewed research that promotes excellence in kidney cancer research.

The review ‘committee’, made up of appointed CUASF grant review members, selects the top 3 submissions, who are invited to present live at the CKCF 2026 Meeting, taking place February 5th – February 7th, 2026, in Toronto, ON. If fewer than 3 submissions are received or submission quality merits fewer acceptances, the review committee reserves the right to select fewer than 3 submissions for final presentation.

Each of the top selected presenters will present for 20 mins followed by 5 minutes Q&A per presenter. After the presentations, the evaluation committee deliberates and ranks the pitches. After the keynote, the judges announce the winners.

Grants will be awarded to the successful applicant. It is anticipated that two grants will be awarded, one for $100,000 and one for $50,000 for 1 year. ($50,000 from CUASF and $100,000 from the Warren Y. Soper Kidney Cancer Research Grant through Kidney Cancer Canada.

Learn More

Eligibility

CUASF will receive and process the submitted proposals. Applicants will be awarded grants based on the following:

  • This research award is designated to support a trainee or faculty member in
  • The applicant or the supervisor must be an active member of KCRNC and the CUA (or must co-apply to either organization at the time of submission if not already a member).
  • Agrees to provide a progress report, including publication plan, to KCRNC for dissemination of study
  • Grant preference may be given to first time

Eligible Research Proposals

The proposals must be in the field of kidney cancer research. Basic science and clinical research projects will be accepted. Preference may be given to junior investigators and to new/pilot projects that have not been previously funded.

The study must be completed within 12 months of receipt of funding; renewals may not be considered. Extensions can be considered for legitimate project delays, with decisions made on a case-by-case basis by the committee. The proposed application should be a ‘stand

alone’ project without other funding.

Non-eligible Research Proposals

The following types of proposals will not be eligible:

  • Proposals for projects that are adequately funded from another source, including government or industry sponsors, will not be eligible unless said funding is shown by the applicant to be directed to a portion of the overall project/research that is separate and distinguishable from the portion to which the proposal
  • Proposals for pharmaceutical product development (including studies on non- approved indications for drugs) and/or product comparison, or product promotion will not be considered.

Review Criteria

The Anil Kapoor Kidney Cancer Research Grant proposals will be reviewed and approved by appointed CUASF grant review members (the ‘review committee’). Research proposals will be evaluated based on the following criteria:
  1. Scientific Merit:
    1. Rationale
    2. Originality
  2. Methodology
  3. Impact
    1. Contribution to advancement of scientific knowledge in Kidney Cancer
    2. Clinical relevance or potential clinical value and applicability
  4. Feasibility
    1. Feasibility of study design, methodology, analysis
    2. Adequate power and sample size
    3. Proposed
  5. Budget
  6. Qualifications of applicant and supporting team
  7. Institutional Support and Resources

RATING SCALE: Score

Rating Scale Description
Priority for Funding
4.8 – 5.0

Outstanding proposal with original and innovative aims. Research proposed is at the forefront internationally and led by outstanding team. The research addresses extremely important questions, challenges existing paradigms and will substantially improve our knowledge of renal cell carcinoma.

Highest
4.5 – 4.7
Exceptional quality research that is highly significant, innovative, and internationally competitive. Driven by an exceptional team, the research addresses crucial questions and will have a major impact on our understanding of renal cell carcinoma.
High
4.2 – 4.4
Excellent quality research that addresses very important and original questions. The research will have a significant impact on the relevant scientific field.
High
3.8 – 4.1
High quality research that can be classified as very good, bordering excellent. The results will likely contribute considerably to knowledge in the scientific field.
Medium
3.4 – 3.7

Very good research that has the potential to improve our current knowledge of kidney cancer. Some minor weaknesses in the proposal, while diminishing enthusiasm, can easily be corrected.

Medium
3.0 – 3.3
Good quality research that may yield important results. There are concerns with the proposal that can be addressed during the term of the grant.
Low
Below 3.0
Research proposal has potential. However, there are weaknesses that need to be reconciled for it to be successful. The proposal is in need of further development before being competitive.
Low

RATING SCALE:

Applications will be ranked on a scale of 1 to 10, ranking will be based on the following:

  • Study Topic in Line with Grant/Award Priorities (Impact)
  • Proposal Synopsis (Importance of Research Question)
  • Objectives/Hypotheses
  • Background
  • Design and Methodology (Feasibility)
  • Investigator/Environment/Supervisor/Infrastructure
  • Appropriateness of Budget
  • Most Pertinent Strengths of Submission
  • Most Pertinent Weaknesses of Submission

Guidelines for Application Format

The research proposal is not to exceed 5 pages in size, Times New Roman font size 12 (not including application form, references, figures and supporting documentation). Do not use condensed/narrow font sizes or type density. Smaller text in tables, charts, figures, and graphs is acceptable, as long as it is legible when the page is viewed at 100%. Use a minimum of single line spacing. Do not use narrow line spacing.
Insert a margin of 2 cm (3/4 inch) – minimum – around the page.

The headings suggested including:

  1. Statement of Objective(s)
  2. Lay Summary (up to 250 words)
  3. Brief review of literature and background information
  4. Hypothesis(es)
  5. Design & Methodology
  6. Analytic Plan
  7. Budget
  8. Overall Impact Statement/Summary


In addition, the following supporting documentation must accompany the application:

  1. Evidence of appropriate Ethics Committee approval or application for approval must be included along with the consent forms where human subjects are involved in the
  2. Letter of support and commitment from the chair of the Department/Division indicating the level of institutional and university
  3. Current curriculum vitae of the applicant and/or the

Obligations for Award Recipients

  1. Presentation of the results of their research at a future KCRNC Forum (which will be supported financially) as well as other national/international meetings and submit their work for publication in peer-reviewed
  2. Acknowledgement of support from KCRNC–KCC-CUASF in all presentations and
  3. Submission of an interim progress report at 6 months, 1 year, and 2 years post funding (if applicable).
  4. Submit a copy of any publications to the KCRNC Project

Financial Considerations

The amount of each Grant should include direct costs (labour and study costs), study drug costs (if applicable), and indirect costs (publication, software license fees, and REB fees). Each payment will be made in installments according to milestones, with a maximum of 50% of the funding delivered at the beginning of the project. Institutions are expected to waive overhead fees that might otherwise apply to industry-funded research.

Teams are encouraged to submit their ethics applications as early as possible and prior to CKCF. This will ensure help to avoid delays in the project start date if grant is awarded.

Amendments can always be submitted post approval.

Enquiries

Address all enquiries to:

Canadian Urological Association Scholarship Foundation

Girish Kulkarni, Chair, Scientific Council c/o Ms. Marfisa Defrancesco marfisa.defrancesco@cua.org

T: 514-606-6073

Apply today

WARREN Y. SOPER KIDNEY CANCER RESEARCH GRANT 2025

Applications Open: July 21th, 2025

Application Submission Deadline: September 26th, 2025

Official winner (s) announcement by November 2025

Background

The Kidney Cancer Research Network of Canada (KCRNC) has entered into a collaboration with Kidney Cancer Canada (KCC) to provide financial support for research within the Canadian kidney cancer research community. Kidney Cancer Canada has received funding from the Warren Y. Soper Trust to fund research projects in 2025.

Objectives and Scope

The objective of the KCRNC Research Grant Program is to support peer-reviewed research that promotes excellence in kidney cancer research. This grant competition is funded by Warren Y. Soper Charitable Trust, via Kidney Cancer Canada.

Grants will be awarded to the successful applicant(s) (or applicant’s institution on behalf of the applicant, if applicable). It is anticipated that one grant(s) will be awarded, for up to $100,000 for 1 year (with possibility of extension). Funding will be provided over a 12-month performance period. Amount per grant to be funded is dependent on the requests and the quality of the applications.

Learn More

Eligibility

The KCRNC Project Manager (Maria Komisarenko, Maria.Komisarenko@uhn.ca )will receive and process the submitted proposals. Proposals will be awarded grants based on the following:

  • This research award is designated to support a faculty member or trainee in Canada.
  • Agrees to provide a progress report, including publication plan, to KCRNC for dissemination of study results.
  • Agrees to acknowledge Kidney Cancer Research Network of Canada, The Warren Y. Soper Charitable Trust, Kidney Cancer Canada in publication for funding.

Eligible Research Proposals

The research proposals must be in kidney cancer research conducted in Canada. Basic science, clinical research projects, and projects identifying unmet supportive care needs and/or improving shared decision-making will be accepted. Preference will be given to the following:

  • Junior investigators (less than 5 years experience) or trainees
  • New/pilot projects that have not been previously funded (this award is not for those looking for fund  extensions to a currently funded project.
  • Projects that are bringing novel advancements to current research

The study must be completed within 12 months of receipt of funding; extensions will be considered. The proposed application should be a ‘stand alone’ project.

Non-eligible Research Proposals

The following types of proposals will not be eligible:

  • Proposals for projects that are adequately funded from another source, including government or industry sponsors, will not be eligible
  • Proposals for pharmaceutical product development (including studies on non-approved indications for

   drugs) and/or product comparison, or product promotion will not be considered.

Review Criteria

The KCRNC-KCC Grant proposals will be reviewed and approved by appointed KCRNC, and Kidney Cancer Canada grant review members. Research proposals will be evaluated based on the following criteria:

  1. Scientific Merit:
    • Rationale
    • Originality
  2. Methodology
  3. Impact
    • Contribution to advancement of scientific knowledge in relevant therapeutic field
    • Clinical relevance or potential clinical value and applicability
  4. Feasibility
    • Feasibility of study design, methodology, analysis
    • Adequate power and sample size
    • Proposed timelines.
  5. Budget
  6. Qualifications of applicant and supporting team
  7. Institutional Support and Resources

RATING SCALE: Score

Rating Scale Description
Priority for Funding
4.8 – 5.0

Outstanding proposal with original and innovative aims. Research proposed is at the forefront internationally and led by outstanding team. The research addresses extremely important questions, challenges existing paradigms and will substantially improve our knowledge of renal cell carcinoma.

Highest
4.5 – 4.7
Exceptional quality research that is highly significant, innovative, and internationally competitive. Driven by an exceptional team, the research addresses crucial questions and will have a major impact on our understanding of renal cell carcinoma.
High
4.2 – 4.4
Excellent quality research that addresses very important and original questions. The research will have a significant impact on the relevant scientific field.
High
3.8 – 4.1
High quality research that can be classified as very good, bordering excellent. The results will likely contribute considerably to knowledge in the scientific field.
Medium
3.4 – 3.7

Very good research that has the potential to improve our current knowledge of kidney cancer. Some minor weaknesses in the proposal, while diminishing enthusiasm, can easily be corrected.

Medium
3.0 – 3.3
Good quality research that may yield important results. There are concerns with the proposal that can be addressed during the term of the grant.
Low
Below 3.0
Research proposal has potential. However, there are weaknesses that need to be reconciled for it to be successful. The proposal is in need of further development before being competitive.
Low
Apply today